The Flu Vaccine Is Little Effect On Men.
The flu vaccine is less productive for men than women, and researchers at Stanford University find credible they've figured out why. The c spear hormone testosterone causes genes in the exempt group to cause fewer antibodies, or defense mechanisms, in answer to the vaccine, they found caliplus cena. "Men, typically, do worse than women in untouched rejoinder to infection and vaccination," said Stanford inspect allied David Furman, the lead study investigator.
For instance, men are more gullible to bacterial, viral, fungal and parasitic infection than women. And men's insusceptible systems don't return as robustly as women's to vaccinations against flu, yellow fever, measles, hepatitis and many other diseases antehealth.com. For the study, published online Dec 23, 2013 in the Proceedings of the National Academy of Sciences, the researchers analyzed the blood of nearly 90 adults after they received a seasonal flu shot.
Men with the highest testosterone levels had the worst retort to the flu vaccine across the board. Testosterone is tied to exemplar masculine genital characteristics, such as muscle strength, beard increase and risk-taking. "We found a set of genes in men that when activated caused a inconsequential effect to the vaccine, but were not confusing in female response calorie. Some of these genes are regulated by testosterone".
It's testosterone's make on these genes that causes the out of pocket vaccine response. "This has a lot of implications for vaccine development". Vaccine reply might be better if men were given twice the dose, he suggested, or c if testosterone levels were reduced. The complete artwork isn't in actuality sparkling or simple. Men's weaker feedback to the flu vaccine is only seen for some strains of flu.
Showing posts with label antibody. Show all posts
Showing posts with label antibody. Show all posts
Friday, 24 November 2017
Sunday, 29 January 2012
Cancer cells can treat tumors
Cancer cells can treat tumors.
New on suggests that many cancer cells are equipped with a variety of suicide pill: a protein on their surfaces that gives them the power to throw an "eat me" striking to immune cells. The summons now, the researchers say, is to mentioned out how to coax cancer cells into emitting the wink rather than a dangerous "don't eat me" signal extreme no ingreece. A bone up published online Dec 22 2010 in Science Translational Medicine reports that the cells delight out the enticing "eat me" outstanding by displaying the protein calreticulin.
But another molecule, called CD47, allows most cancer cells to refrain from wrecking by sending the reverse signal: "Don't nosh me". In earlier research, Stanford University School of Medicine scientists found that an antibody that blocks CD47 - turning off the unusual - could assistant against cancer, but mysteries remained powered by mybb smoke shops in iowa. "Many reasonable cells in the body have CD47, and yet those cells are not touched by the anti-CD47 antibody," Mark Chao, a Stanford or alumna disciple and the study's lead author, said in a university report release.
New on suggests that many cancer cells are equipped with a variety of suicide pill: a protein on their surfaces that gives them the power to throw an "eat me" striking to immune cells. The summons now, the researchers say, is to mentioned out how to coax cancer cells into emitting the wink rather than a dangerous "don't eat me" signal extreme no ingreece. A bone up published online Dec 22 2010 in Science Translational Medicine reports that the cells delight out the enticing "eat me" outstanding by displaying the protein calreticulin.
But another molecule, called CD47, allows most cancer cells to refrain from wrecking by sending the reverse signal: "Don't nosh me". In earlier research, Stanford University School of Medicine scientists found that an antibody that blocks CD47 - turning off the unusual - could assistant against cancer, but mysteries remained powered by mybb smoke shops in iowa. "Many reasonable cells in the body have CD47, and yet those cells are not touched by the anti-CD47 antibody," Mark Chao, a Stanford or alumna disciple and the study's lead author, said in a university report release.
Subscribe to:
Posts (Atom)